Join us as we lead the fight for a world without cancer.
Funds raised will provide needed support for the most promising cancer research locally and beyond. Since 1946, the American Cancer Society has invested more than $4.5 billion in cancer research and has played a critical role in almost every major cancer research breakthrough.
Locally, the American Cancer Society is currently investing more than $11.2 million in researchers based at Fred Hutchinson Cancer Research Center, Seattle Children’s, and the University of Washington. At the national level, we are investing over $406 million to fund scientists and medical professionals whose life-saving research is conducted at medical schools, universities, research institutes, and hospitals across the United States.
As the nation’s largest private, non-profit source of funds for cancer research, we ensure research dollars go to the best science in the U.S. through an extensive peer-review process. We invest in the best research which will make critical advances in prevention, early detection, treatment, and care for those with cancer. This research funding strategy has helped support numerous important discoveries from some of the brightest researchers, including 47 Nobel Prize winners to date.
To make a donation, please click the button below
or contact Dawn Draves at or 206.674.4146.
Meet Dr. Maziarz
Last year guests of the Hope Gala raised their paddles high and gave generously to support our mission to save lives, celebrate lives and lead the fight for a world without cancer. A total of $160,000 was pledged directly to fund life-saving and vital research.
Research is the greatest tool we have in the fight against cancer. One rarely has the chance to play a direct role in a specific scientific discovery that saves lives. As supporters of our mission, we are excited to update you on the way in which these generous gifts are being invested in the fight against cancer. Recently, our experts provided an evaluation committee of donors with 6 outstanding candidates applying for research grant funding. After thoughtful review and lively debate, the grant has been awarded to Dr. Marcin Maziarz, PhD, an investigator at Boston University.
Dr Maziarz is working to develop a biosensor to rapidly and specifically identify G protein mutations to determine a way to kill those identified cells harboring the G protein mutations, which can cause a vast array of diseases including cancer. This could identify a new novel method for new therapeutic strategies for fighting cancer.